CytomX Therapeutics, Inc.
Activatable anti-PDL1 antibodies, and methods of use thereof

Abstract:

The invention relates generally to activatable antibodies that specifically bind to PDL1 and methods of making and using these anti-PDL1 activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.